Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2014
 •  President Signs Sunscreen Innovation Act  •  Rob Lowe, The Formulator  •  Body Shop Donating To War Child  •  L’Oréal To Honor Social Responsibility in Dermatology  •  Clariant Reaches ISO22716 and EFfci GMP Milestone
Print

FDA in India Serves Notice to Wipro



Published December 9, 2005
Related Searches: baby brand label fda
Post a comment
MUMBAI: The Maharashtra Food and Drug Administration (FDA) served a notice to Wipro for allegedly “misbranding and mislabeling” its baby oil.
“We have served notice to Wipro for misbranding and labeling deficiency or mislabeling its baby oil manufactured under the name Wipro Baby Soft,” FDA commissioner A. Ramkrishnan said.


blog comments powered by Disqus